Physician profile
Robert A Dein
NPI 1104871300
$5,549.28
in general payments reported to CMS, 2019-2025
32 companies · $575 in 2025
The $575 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $288 · 2021: $2,223 · 2022: $497 · 2023: $667 · 2024: $594 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783 · Education: $53.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.70 |
| Education | $53.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,952.10 | 2019-2024 | |
| Abbvie INC. | $685.01 | 2019-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $494.66 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $448.43 | 2023-2025 | Myfembree, Gemtesa |
| Amgen INC. | $422.52 | 2019-2025 | Evenity, Prolia |
| Aspira Women'S Health INC | $274.11 | 2021-2024 | Ova1 |
| Therapeuticsmd, INC. | $137.51 | 2019-2022 | |
| Coopersurgical, INC. | $112.85 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Millicent US INC | $109.94 | 2019-2025 | Femring, Intrarosa |
| Amag Pharmaceuticals, INC. | $78.74 | 2019 | |
| Myovant Sciences INC. | $78.61 | 2021-2022 | |
| Conmed Corporation | $74.00 | 2019 | |
| Shield Therapeutics INC | $69.06 | 2023-2024 | Accrufer |
| Medtronic, INC. | $64.52 | 2021-2023 | Truclear |
| Urovant Sciences INC | $55.53 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $52.51 | 2019-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $43.09 | 2020 | |
| Hologic Sales and Service, LLC | $40.02 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Irhythm Technologies, INC. | $38.81 | 2024 | Zio Monitor, Zio Xt Patch |
| Allergan, INC. | $37.13 | 2019 | |
| Sage Therapeutics, LLC | $36.44 | 2024 | |
| Evofem Biosciences, INC. | $30.40 | 2024-2025 | Solosec, Phexx, Phexxi |
| Avion Pharmaceuticals | $27.68 | 2019-2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $26.61 | 2023 | |
| Vertical Pharmaceuticals, LLC | $26.56 | 2019 | |
| Exact Sciences Corporation | $26.16 | 2024 | Cologuard Collection Kit |
| Vertex Pharmaceuticals Incorporated | $23.75 | 2024 | |
| Mylan Pharmaceuticals INC. | $20.97 | 2022 | |
| Caldera Medical, INC | $20.42 | 2023 | Desara |
| Neuronetics, INC. | $14.57 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.36 | 2019 | |
| Meditrina | $13.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.